Pascal Vranckx
Impact in
- Cardiology and Cardiovascular Medicine top 0.05%
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Cardiac Valve Diseases and Treatments
- Atrial Fibrillation Management and Outcomes
- Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 32
- Atrial Fibrillation Management and Outcomes 29
- Acute Myocardial Infarction Research 27
- Cardiac Valve Diseases and Treatments 12
- Surgery 55
- Coronary Interventions and Diagnostics 38
- Co-authors
- Roxana Mehran (23 shared papers)Donald E. Cutlip (17 shared papers)Patrick W. Serruys (48 shared papers)Stephan Windecker (43 shared papers)Mitchell W. Krucoff (7 shared papers)Philippe Gabríel Steg (17 shared papers)Marco Valgimigli (64 shared papers)Marie‐Angèle Morel (6 shared papers)
- Journals
- European Heart Journal Acute Cardiovascular Care (22 papers)EuroIntervention (22 papers)European Heart Journal (15 papers)Journal of the American College of Cardiology (14 papers)Circulation (9 papers)
- Partner nations
- BelgiumNetherlandsSwitzerland
In The Last Decade
Pascal Vranckx
155 papers receiving 16.4k citations
Pascal Vranckx's Hit Papers
Peers
Comparison fields: 5 of 135
- Cardiology and Cardiovascular Medicine 9.3k
- Internal Medicine 946
- Surgery 6.8k
- Radiology, Nuclear Medicine and Imaging 1.4k
- Emergency Medicine 354
Countries citing papers authored by Pascal Vranckx
This map shows the geographic impact of Pascal Vranckx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Vranckx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Vranckx more than expected).
Fields of papers citing papers by Pascal Vranckx
This network shows the impact of papers produced by Pascal Vranckx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Vranckx. The network helps show where Pascal Vranckx may publish in the future.
Co-authors
The 25 scholars most cited alongside Pascal Vranckx, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical End Points in Coronary Stent Trials Hit paper breakdown → | 2007 | 4261 |
| 2 | Standardized Bleeding Definitions for Cardiovascular Clinical Trials Hit paper breakdown → | 2011 | 3028 |
| 3 | Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium Hit paper breakdown → | 2011 | 912 |
| 4 | Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document Hit paper breakdown → | 2018 | 565 |
| 5 | Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials Hit paper breakdown → | 2011 | 558 |
| 6 | Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting Hit paper breakdown → | 2012 | 449 |
| 7 | Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial Hit paper breakdown → | 2019 | 404 |
| 8 | 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Hit paper breakdown → | 2018 | 377 |
| 9 | Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions Hit paper breakdown → | 2015 | 369 |
| 10 | 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Hit paper breakdown → | 2017 | 338 |
| 11 | 2010 | 225 | |
| 12 | 2010 | 185 | |
| 13 | 2011 | 181 | |
| 14 | 2019 | 180 | |
| 15 | 2009 | 178 | |
| 16 | 2018 | 168 | |
| 17 | 2015 | 151 | |
| 18 | 2016 | 144 | |
| 19 | 2020 | 135 | |
| 20 | 2014 | 125 |
About Pascal Vranckx
Pascal Vranckx is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Biomedical Engineering, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 167 papers that have together received 16.7k indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (38 papers), Antiplatelet Therapy and Cardiovascular Diseases (32 papers), Atrial Fibrillation Management and Outcomes (29 papers), Acute Myocardial Infarction Research (27 papers), Mechanical Circulatory Support Devices (18 papers), Cardiac Imaging and Diagnostics (12 papers), Cardiac Valve Diseases and Treatments (12 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (9.3k citations), Internal Medicine (946 citations), Surgery (6.8k citations), Radiology, Nuclear Medicine and Imaging (1.4k citations) and Emergency Medicine (354 citations). Pascal Vranckx has collaborated with scholars based in Belgium, Netherlands and Switzerland. Frequent co-authors include Roxana Mehran, Donald E. Cutlip, Patrick W. Serruys, Stephan Windecker, Mitchell W. Krucoff, Philippe Gabríel Steg, Marco Valgimigli, Marie‐Angèle Morel, Gerrit‐Anne van Es and Eugène McFadden. Their work appears in journals such as European Heart Journal Acute Cardiovascular Care, EuroIntervention, European Heart Journal, Journal of the American College of Cardiology and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.